Cyber Risk on the Front Lines of Pharma

To Combat Attacks, Drug and Life Sciences Companies Must Combat Lateral Threat Movement on Their Networks

The pharmaceutical and healthcare industries are more targeted than ever in the wake of the COVID-19 pandemic and the development of its vaccines and treatments. 70% of successful attacks involve lateral movement within the network — and once attackers are inside undetected, perimeter defenses are useless.

This whitepaper provides insight on some of the primary cybersecurity challenges facing pharma and healthcare companies, including targeted ransomware, insider threats, and difficult-to-secure OT, IoT and IoMT devices.

Get Whitepaper
Cyber Risk on the Frontlines of Pharma

Download the whitepaper to learn:

  • Shrinking the attack surface through automated discovery and elimination of exploitable credentials and pathways
  • Detecting early malicious lateral movement through deterministic, endpoint-based deception
  • Leveraging source-based forensics on demand, contextual data needed to accelerate and respond quickly